Diego Cecchini

10PUBLICATIONS
39CO-AUTHORS
Gene and molecular therapyVirologyMajor global burdens of diseaseDisease surveillanceHealth informatics and information systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 16, 2026
Long-term persistence, effectiveness, safety, and metabolic impact of bictegravir/emtricitabine/tenofovir alafenamide fixed-dose combination in people living with HIV in the BICTARG cohort.

|Aug 28, 2025
Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts <200/mm3: 48-Week Results of the DOLCE Study.

Maria Ines Figueroa, Carlos Brites, Diego Cecchini

|Jul 14, 2025
Global "expiration" of abacavir in adults with HIV: a rapid review of safety and efficacy concerns challenging its role in modern ART.

David B Cluck, Daniel B Chastain, Jacob D Lines

|Jun 16, 2025
Effectiveness and safety of dual therapy with co-packaged dolutegravir and lamivudine compared to triple therapy as switching strategy in clinical practice.

Diego Cecchini, Edgardo Bottaro, Brenda Bacelar

|May 28, 2025
Prevalence of Doravirine Resistance Mutations in a Large-Scale HIV-1 Transmitted Drug Resistance Survey in Buenos Aires, Argentina.

Diego Cecchini, Isabel Cassetti, Florencia Scarnato

|Apr 24, 2024
Telemedicine in HIV health care during the COVID-19 pandemic: An implementation research study in Buenos Aires, Argentina.

Manuela Bullo, Tomas Kierszenowicz, Maria Cecilia Acosta

Pageof 2

Frequent Collaborators

2 joint publications

Omar Sued

2 joint publications

Isabel Cassetti

2 joint publications

Macarena Roel

2 joint publications

Brenda Bacelar